Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Community outbreak of hepatitis A disproportionately affecting men who have sex with men in Toronto, Canada, January 2017-November 2018.

Sachdeva H, Benusic M, Ota S, Stuart R, Maclachlan J, Dubey V, Andonov A.

Can Commun Dis Rep. 2019 Oct 3;45(10):262-268. doi: 10.14745/ccdr.v45i10a03. eCollection 2019 Oct 3.

2.

Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent Patient.

Andonov A, Robbins M, Borlang J, Cao J, Hatchette T, Stueck A, Deschambault Y, Murnaghan K, Varga J, Johnston L.

J Infect Dis. 2019 Aug 9;220(6):951-955. doi: 10.1093/infdis/jiz025.

PMID:
30649379
3.

Hepatitis A virus infection associated with cannabis use.

Sikora C, Tipples G, Pang XL, Andonov A.

Can Commun Dis Rep. 2017 Nov 2;43(11):245-246. eCollection 2017 Nov 2.

4.

Hepatitis E in Canadian blood donors.

Fearon MA, O'Brien SF, Delage G, Scalia V, Bernier F, Bigham M, Weger S, Prabhu S, Andonov A.

Transfusion. 2017 Jun;57(6):1420-1425. doi: 10.1111/trf.14089. Epub 2017 Apr 10.

PMID:
28394029
5.

Transmission of hepatitis D virus between spouses: A longitudinal study of the first reported Canadian case.

Osiowy C, Andonov A, Fonseca K, Swidinsky K, Giles E, Mason A, Coffin CS.

IDCases. 2017 Mar 6;8:37-41. doi: 10.1016/j.idcr.2017.03.001. eCollection 2017.

6.

Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy.

Osiowy C, Coffin C, Andonov A.

Curr Treat Options Infect Dis. 2016;8:177-193. Epub 2016 Jul 2. Review.

7.

Outbreak of acute hepatitis B virus infection associated with exposure to acupuncture.

Rempel S, Murti M, Buxton JA, Stephens W, Watterson M, Andonov A, Fung C, Ramler G, Bigham M, Lem M.

Can Commun Dis Rep. 2016 Aug 4;42(8):169-172. eCollection 2016 Aug 4.

8.

Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya.

Ochwoto M, Kimotho JH, Oyugi J, Okoth F, Kioko H, Mining S, Budambula NL, Giles E, Andonov A, Songok E, Osiowy C.

BMC Infect Dis. 2016 Mar 1;16:101. doi: 10.1186/s12879-016-1409-2.

9.

Hepatitis E Virus Seroprevalence in Free-Ranging Deer in Canada.

Weger S, Elkin B, Lindsay R, Bollinger T, Crichton V, Andonov A.

Transbound Emerg Dis. 2017 Jun;64(3):1008-1011. doi: 10.1111/tbed.12462. Epub 2016 Jan 11.

PMID:
26752436
10.

HIV and hepatitis C virus co-infection in Kenya.

Andonov A, Songok E, Ochwoto M, Osiowy C, Ball TB.

Lancet Infect Dis. 2015 Dec;15(12):1377-8. doi: 10.1016/S1473-3099(15)00403-X. Epub 2015 Nov 16. No abstract available.

PMID:
26607120
11.

Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada.

Osiowy C, Giles E, Trubnikov M, Choudhri Y, Andonov A.

PLoS One. 2015 Sep 25;10(9):e0136074. doi: 10.1371/journal.pone.0136074. eCollection 2015.

12.

Hepatitis E.

Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.

Vox Sang. 2016 Jan;110(1):93-130. doi: 10.1111/vox.12285. Epub 2015 Jul 21. No abstract available.

PMID:
26198159
13.

Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic.

Willmore J, Ellis E, Etches V, Labrecque L, Osiowy C, Andonov A, McDermaid C, Majury A, Achonu C, Maher M, MacLean B, Levy I.

Can J Infect Dis Med Microbiol. 2015 Mar-Apr;26(2):77-84.

14.

Distribution of Hepatitis C virus genotypes among newly acquired HCV infections in British Columbia (2000-2013).

Andonov A, Lin L, McGuinness L, Krajden M.

Can Commun Dis Rep. 2014 Dec 18;40(19):437-443. eCollection 2014 Dec 18.

15.

Hepatitis A outbreak in British Columbia, Canada: the roles of established surveillance, consumer loyalty cards and collaboration, February to May 2012.

Swinkels HM, Kuo M, Embree G; Fraser Health Environmental Health Investigation Team, Andonov A, Henry B, Buxton JA.

Euro Surveill. 2014 May 8;19(18). pii: 20792.

16.

Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma.

Andonov A, Rock G, Lin L, Borlang J, Hooper J, Grudeski E, Wu J; Members of the Canadian Apheresis Group (CAG).

Vox Sang. 2014 Oct;107(3):213-9. doi: 10.1111/vox.12156. Epub 2014 May 15.

PMID:
24830322
17.

Hepatitis B and hepatitis C viral infections in patients with chronic lymphocytic leukemia.

Minuk GY, Lerner B, Gibson SB, Johnston JB, Uhanova J, Andonov A, Wu J.

Can J Gastroenterol Hepatol. 2014 Mar;28(3):131-4.

18.
19.

Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.

Lu Y, Andonov A, Wong DK.

J Clin Microbiol. 2014 Jan;52(1):367-9. doi: 10.1128/JCM.01367-13. Epub 2013 Oct 30.

21.

Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada.

Andonov A, Coulthart MB, Pérez-Losada M, Crandall KA, Posada D, Padmore R, Giulivi A, Oger JJ, Peters AA, Dekaban GA.

Infect Genet Evol. 2012 Dec;12(8):1822-30. doi: 10.1016/j.meegid.2012.07.015. Epub 2012 Aug 13.

PMID:
22921499
22.

Canadian hepatitis C look-back investigation to detect transmission from an infected general surgeon.

Dawar M, Stuart TL, Sweet LE, Neatby AM, Abbott LP, Andonov AP, Wong T, Gervais R, Stirling R.

Can J Infect Dis Med Microbiol. 2010 Spring;21(1):e6-e11.

23.

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.

Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.

MAbs. 2010 Jan-Feb;2(1):53-66. Epub 2010 Jan 27.

24.

The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.

Tylor S, Andonov A, Cutts T, Cao J, Grudesky E, Van Domselaar G, Li X, He R.

Can J Microbiol. 2009 Mar;55(3):254-60. doi: 10.1139/w08-139.

PMID:
19370068
25.

Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia.

Panessa C, Hill WD, Giles E, Yu A, Harvard S, Butt G, Andonov A, Krajden M, Osiowy C.

J Viral Hepat. 2009 Jan;16(1):64-73. doi: 10.1111/j.1365-2893.2008.01045.x.

PMID:
19192159
26.

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.

Patrick DM, Petric M, Skowronski DM, Guasparini R, Booth TF, Krajden M, McGeer P, Bastien N, Gustafson L, Dubord J, Macdonald D, David ST, Srour LF, Parker R, Andonov A, Isaac-Renton J, Loewen N, McNabb G, McNabb A, Goh SH, Henwick S, Astell C, Guo JP, Drebot M, Tellier R, Plummer F, Brunham RC.

Can J Infect Dis Med Microbiol. 2006 Nov;17(6):330-6.

27.

Enhanced surveillance for acute and likely acute hepatitis B in Canada: 1999 to 2002.

Boulos D, Goedhuis NJ, Wu J, Baptiste B, Poliquin D, Furseth J, Chan JI, Bolesnikov G, Barichello F, Andonov A, Giulivi A.

Can J Infect Dis Med Microbiol. 2005 Sep;16(5):275-81.

28.

Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion.

Beniac DR, deVarennes SL, Andonov A, He R, Booth TF.

PLoS One. 2007 Oct 24;2(10):e1082.

29.

Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada.

Spinelli JJ, Lai AS, Krajden M, Andonov A, Gascoyne RD, Connors JM, Brooks-Wilson AR, Gallagher RP.

Int J Cancer. 2008 Feb 1;122(3):630-3.

30.

Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004.

Wu HX, Wu J, Wong T, Andonov A, Li Q, Dinner K, Donaldson T, Paton S; Enhanced Hepatitis Strain Surveillance System (c/o Ms. Marlene Huard, Executive Assistant).

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):167-74.

PMID:
17308895
31.

Human T-cell lymphotropic virus type 1-associated adult T-cell leukemia/lymphoma in the Inuit people of Nunavut.

Fahim S, Prokopetz R, Jackson R, Faught C, McCarthy AE, Andonov A, Coulthart M, Daw Z, Olberg B, Giulivi A, Padmore R.

CMAJ. 2006 Sep 12;175(6):579. No abstract available.

32.

Architecture of the SARS coronavirus prefusion spike.

Beniac DR, Andonov A, Grudeski E, Booth TF.

Nat Struct Mol Biol. 2006 Aug;13(8):751-2. Epub 2006 Jul 16.

PMID:
16845391
33.

Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.

Wu HX, Wu J, Wong T, Donaldson T, Dinner K, Andonov A, Ip Chan J, Moffat B, Baptiste B, Furseth J, Poliquin D, Bolesnikov G, Giulivi A, Paton S.

Scand J Infect Dis. 2006;38(6-7):482-9.

PMID:
16798699
34.

Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003.

Wu HX, Andonov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JI, Bolesnikov G, Moffat B, Paton S, Wu J.

Int J Med Sci. 2005;2(4):143-6. Epub 2005 Oct 1.

35.

Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Antonishyn NA, Ast VM, McDonald RR, Chaudhary RK, Lin L, Andonov AP, Horsman GB.

J Clin Microbiol. 2005 Oct;43(10):5158-63.

36.

Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods.

Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J.

Diagn Microbiol Infect Dis. 2005 Sep;53(1):47-55.

PMID:
15994050
37.

Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins.

Yap Y, Zhang X, Andonov A, He R.

Comput Biol Chem. 2005 Jun;29(3):212-9.

PMID:
15979041
38.

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.

Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J.

J Virol. 2004 Nov;78(22):12672-6.

39.

Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus.

Gubbins MJ, Plummer FA, Yuan XY, Johnstone D, Drebot M, Andonova M, Andonov A, Berry JD.

Mol Immunol. 2005 Jan;42(1):125-36.

PMID:
15488951
40.

Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus.

He R, Leeson A, Ballantine M, Andonov A, Baker L, Dobie F, Li Y, Bastien N, Feldmann H, Strocher U, Theriault S, Cutts T, Cao J, Booth TF, Plummer FA, Tyler S, Li X.

Virus Res. 2004 Oct;105(2):121-5.

PMID:
15351485
41.

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.

Berry JD, Jones S, Drebot MA, Andonov A, Sabara M, Yuan XY, Weingartl H, Fernando L, Marszal P, Gren J, Nicolas B, Andonova M, Ranada F, Gubbins MJ, Ball TB, Kitching P, Li Y, Kabani A, Plummer F.

J Virol Methods. 2004 Sep 1;120(1):87-96.

PMID:
15234813
42.

Analysis of multimerization of the SARS coronavirus nucleocapsid protein.

He R, Dobie F, Ballantine M, Leeson A, Li Y, Bastien N, Cutts T, Andonov A, Cao J, Booth TF, Plummer FA, Tyler S, Baker L, Li X.

Biochem Biophys Res Commun. 2004 Apr 2;316(2):476-83.

PMID:
15020242
43.

Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein.

He R, Leeson A, Andonov A, Li Y, Bastien N, Cao J, Osiowy C, Dobie F, Cutts T, Ballantine M, Li X.

Biochem Biophys Res Commun. 2003 Nov 28;311(4):870-6.

PMID:
14623261
44.

Mass spectrometric characterization of proteins from the SARS virus: a preliminary report.

Krokhin O, Li Y, Andonov A, Feldmann H, Flick R, Jones S, Stroeher U, Bastien N, Dasuri KV, Cheng K, Simonsen JN, Perreault H, Wilkins J, Ens W, Plummer F, Standing KG.

Mol Cell Proteomics. 2003 May;2(5):346-56. Epub 2003 May 29.

45.

The Genome sequence of the SARS-associated coronavirus.

Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL.

Science. 2003 May 30;300(5624):1399-404. Epub 2003 May 1.

46.
47.

Predominance of hepatitis C virus genotype 1b in Bulgaria.

Andonov A, Teoharov P, Bakalova S.

Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):521-3. No abstract available.

PMID:
8839651
48.

Subtyping of hepatitis C virus isolates by a line probe assay using hybridization.

Andonov A, Chaudhary RK.

J Clin Microbiol. 1995 Jan;33(1):254-6.

49.

Genotyping of Canadian hepatitis C virus isolates by PCR.

Andonov A, Chaudhary RK.

J Clin Microbiol. 1994 Aug;32(8):2031-4.

50.

Supplemental Content

Loading ...
Support Center